Compounds > niacinamide

niacinamide and bilirubin

niacinamide has been researched along with bilirubin in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-199011 (39.29)18.7374
1990's0 (0.00)18.2507
2000's1 (3.57)29.6817
2010's14 (50.00)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Pagliaro, L1
Careddu, P; Marini, A1
Cavallaro, A; Laghi, V; Rossi, L1
Eagles, JA; Neville, JN; Olson, RE; Samson, G1
Careddu, P; Flauto, U; Marini, A1
Kanagawa, H1
Baba, K1
Boyer, JL; Winter, SL1
Fujimoto, JM; Smith, DS1
Aken, HV; Bone, HG; Meyer, J; Nofer, JR; Scharte, M; Waurick, R1
ESPOSITO, S1
CALI, G; LOCOCO, G; PIETROPAOLO, C1
Fischer, L; Herden, U; Nashan, B; Schäfer, H; Sterneck, M; von Baehr, V1
Abbas, H; Bancelin, N; Blanchet, B; Boudou-Rouquette, P; Coriat, R; Dauphin, A; Durand, JP; Goldwasser, F; Michels, J; Mir, O; Ropert, S; Taieb, F; Thomas-Schoemann, A; Tod, M; Vidal, M1
Bruix, J; Dominguez, S; Germanidis, G; Greten, TF; Hilgard, P; Llovet, JM; Mazzaferro, V; Moscovici, M; Nadel, A; Raoul, JL; Ricci, S; Scherubl, H; Scheulen, ME; Sherman, M; Voliotis, D1
Dahut, W; English, BC; Federspiel, J; Figg, WD; Gardner, ER; Giaccone, G; Jain, L; Kim, A; Kirkland, CT; Kohn, E; Kummar, S; Peer, CJ; Richardson, ED; Sissung, TM; Troutman, SM; Venzon, D; Widemann, B; Woo, S; Yarchoan, R1
Andersen, KJ; Hamilton-Dutoit, S; Kannerup, AS; Knudsen, AR; Ladekarl, M; Mortensen, FV; Nyengaard, JR; Sasanuma, H1
Agrogiannis, G; Chatziioannou, AN; Fokas, D; Kavatzas, N; Kostomitsopoulos, NG; Loxas, D; Malagari, K; Siskos, AP; Tamvakopoulos, C; Tsigkou, O1
Chiba, T; Kanai, F; Kanogawa, N; Motoyama, T; Ogasawara, S; Ooka, Y; Saito, T; Suzuki, E; Tawada, A; Yokosuka, O1
Blanc, JF; Campillo-Gimenez, B; Collins, P; Darby, S; Edeline, J; Evans, J; Hubner, RA; Iwuji, C; Johnson, P; King, J; Ma, YT; Meyer, T; Muazzam, I; Palmer, DH; Patel, K; Ross, P; Sumpter, K; Swinson, D1
Burns, K; Chau, N; Kichenadasse, G; Knights, KM; Mackenzie, PI; McKinnon, RA; Miners, JO; Rowland, A; Tucker, GT1
Arizumi, T; Bettinger, D; Burlone, ME; Kudo, M; Pinato, DJ; Pirisi, M; Ramaswami, R; Sharma, R; Thimme, R; Ward, C; Yen, C1
Chen, CH; Hu, TH; Hung, CH; Kee, KM; Kuo, YH; Lu, SN; Rau, KM; Wang, JH; Wu, IP1
Blanc, JF; Campillo-Gimenez, B; Edeline, J; Faluyi, O; Ghazi, S; King, J; Ma, YT; Mathurin, J; Meyer, T; Palmer, DH1
Deguchi, A; Hiasa, Y; Hiraoka, A; Hirooka, M; Imai, M; Ishikawa, T; Joko, K; Koizumi, Y; Kudo, M; Kumada, T; Michitaka, K; Ochi, H; Shimada, N; Tada, T; Tajiri, K; Toyoda, H; Tsuji, K1
Kang, MK; Lee, HJ; Park, JG1
Fujita, M; Imai, SI; Inagaki, E; Irie, J; Itoh, H; Mitsuishi, M; Nabeshima, YI; Nakaya, H; Okano, H; Ono, T; Shigaki, S; Tsubota, K; Yamaguchi, S; Yamashita, K; Yasui, M; Yukioka, H1
Antonova, EA; Belikova, TN; Kovalenko, AL; Morozov, VG; Popova, VB; Rafalskiy, VV; Stel'makh, VV; Uspenskiy, YP1

Reviews

1 review(s) available for niacinamide and bilirubin

ArticleYear
[Neonatal jaundice].
    Nihon rinsho. Japanese journal of clinical medicine, 1972, Volume: 30, Issue:9

    Topics: Bilirubin; Breast Feeding; Carrier Proteins; Female; Glucuronates; Humans; Infant, Newborn; Jaundice, Neonatal; Liver; Niacinamide; Phenobarbital; Protein Binding; Proteins; Transferases

1972

Trials

5 trial(s) available for niacinamide and bilirubin

ArticleYear
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
    Journal of hepatology, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; alpha-Fetoproteins; Antineoplastic Agents; Aspartate Aminotransferases; Benzenesulfonates; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Sorafenib; Survival Rate; Treatment Outcome

2012
Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Investigational new drugs, 2015, Volume: 33, Issue:6

    Topics: Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; Disease Progression; Exanthema; Fatigue; Female; Humans; Liver Function Tests; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Prospective Studies; Serum Albumin; Serum Albumin, Human; Sorafenib; Treatment Outcome

2015
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
    Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:6

    Topics: Adult; Aged; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Prognosis; Serum Albumin; Sorafenib

2017
Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
    Endocrine journal, 2020, Feb-28, Volume: 67, Issue:2

    Topics: Administration, Oral; Adult; Bilirubin; Blood Glucose; Blood Pressure; Body Temperature; Chlorides; Chromatography, Liquid; Creatinine; Diagnostic Techniques, Ophthalmological; Dose-Response Relationship, Drug; Electrocardiography; Healthy Volunteers; Heart Rate; Humans; Intraocular Pressure; Japan; Male; Middle Aged; Niacinamide; Nicotinamide Mononucleotide; Oxygen; Pyridones; Sleep; Tandem Mass Spectrometry; Visual Acuity

2020
[The results of phase III multicenter open randomized controlled study REM-Chol-III-16 in patients with intrahepatic cholestasis syndrome caused by chronic diffuse liver diseases].
    Terapevticheskii arkhiv, 2021, Dec-15, Volume: 93, Issue:12

    Topics: Alkaline Phosphatase; Bilirubin; Cholestasis, Intrahepatic; gamma-Glutamyltransferase; Humans; Inosine; Meglumine; Methionine; Niacinamide; S-Adenosylmethionine; Succinic Acid; Transaminases

2021

Other Studies

22 other study(ies) available for niacinamide and bilirubin

ArticleYear
[Treatment of patients with chronic liver diseases with a hepatotrophic preparation].
    Minerva medica, 1971, Jul-21, Volume: 62, Issue:57

    Topics: Bilirubin; Cholinesterases; Chronic Disease; Folic Acid; gamma-Globulins; Hepatitis; Humans; Liver Cirrhosis; Methionine; Niacinamide; Nucleosides; Riboflavin; Serum Albumin; Vitamin B 12

1971
Stimulating bilirubin conjugation.
    Lancet (London, England), 1968, May-04, Volume: 1, Issue:7549

    Topics: Bilirubin; Female; Humans; Hyperbilirubinemia, Hereditary; Infant, Newborn; Niacinamide; Pregnancy; Twins; Uracil Nucleotides

1968
[Research on the hepatoprotective effect of 1-amino acids involved in the Krebs-Henseleit cycle associated with vitamins].
    Minerva medica, 1968, Sep-19, Volume: 59, Issue:75

    Topics: Aged; Amino Acids; Bilirubin; Female; Folic Acid; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Niacinamide; Transaminases; Vitamin B 12

1968
Nutritional status of alcoholics.
    The American journal of clinical nutrition, 1968, Volume: 21, Issue:11

    Topics: Adult; Alcoholism; Bilirubin; Blood Proteins; Dietary Proteins; Female; Humans; Liver Function Tests; Male; Medical History Taking; Middle Aged; Niacinamide; Nicotinic Acids; Nutrition Surveys; Riboflavin; Serum Albumin; Sex Factors; Thiamine; Vitamins

1968
[Administration of uridinediphosphoglucose (UDPG) and behavior of blood bilirubin in the newborn].
    Minerva pediatrica, 1969, Jul-28, Volume: 21, Issue:30

    Topics: Bilirubin; Diseases in Twins; Glucose; Humans; Hyperbilirubinemia; Infant, Newborn; Infant, Premature, Diseases; Jaundice, Neonatal; Niacinamide; Nucleoside Diphosphate Sugars; Uracil Nucleotides

1969
2-Pyridone excretion after nicotinamide loading as a liver function test.
    The Kumamoto medical journal, 1972, Mar-31, Volume: 25, Issue:1

    Topics: Adult; Aged; Bilirubin; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Niacinamide; Pyridones

1972
Hepatic toxicity from large doses of vitamin B3 (nicotinamide).
    The New England journal of medicine, 1973, Nov-29, Volume: 289, Issue:22

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Biopsy; Chemical and Drug Induced Liver Injury; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Niacinamide

1973
Alterations produced by novobiocin during biliary excretion of morphine, morphine-3-glucuronide and other compounds.
    The Journal of pharmacology and experimental therapeutics, 1974, Volume: 188, Issue:3

    Topics: Analysis of Variance; Animals; Bile; Bilirubin; Carbon Radioisotopes; Digitoxin; Glucuronates; Liver; Male; Mannitol; Morphine; Niacinamide; Novobiocin; Ouabain; Procainamide; Rats; Sulfobromophthalein; Time Factors; Tritium; Tubocurarine

1974
Nicotinamide increases systemic vascular resistance in ovine endotoxemia.
    Intensive care medicine, 2003, Volume: 29, Issue:6

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxemia; Female; gamma-Glutamyltransferase; Inflammation; Infusions, Intravenous; Injections, Intravenous; Niacinamide; Nitrates; Nitrites; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prospective Studies; Random Allocation; Sheep; Typhoid Fever; Vascular Resistance

2003
[The action of nicotinamide and nicotinic acid on hemopoiesis and hemocatheresis. The behavior of sideremia and bilirubinemia in normal and splenectomized animals treated with nicotinic acid].
    Haematologica, 1960, Volume: 45

    Topics: Animals; Bilirubin; Hematopoiesis; Hyperbilirubinemia; Iron; Niacin; Niacinamide; Nicotinic Acids

1960
[INFLUENCE OF SUBSTANCES WITH A PYRIDINE NUCLEUS ON SIDEREMIC AND BILIRUBINEMIC LEVELS].
    Bollettino della Societa italiana di cardiologia, 1964, Volume: 9

    Topics: Bilirubin; Blood; Hyperbilirubinemia; Iron; Niacin; Niacinamide; Nicotinic Acids; Pharmacology; Pyridines; Pyridoxine; Vasodilator Agents

1964
Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient.
    Transplantation, 2010, Jul-15, Volume: 90, Issue:1

    Topics: Acute Disease; Antineoplastic Agents; Benzenesulfonates; Bilirubin; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome

2010
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.
    Pharmaceutical research, 2011, Volume: 28, Issue:12

    Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Bilirubin; Female; Humans; Male; Neoplasms; Niacinamide; Orosomucoid; Phenylurea Compounds; Protein Binding; Protein Kinase Inhibitors; Pyridines; Serum Albumin; Sorafenib; Young Adult

2011
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Apr-01, Volume: 18, Issue:7

    Topics: Aged; Antineoplastic Agents; Area Under Curve; Benzenesulfonates; Bilirubin; Clinical Trials as Topic; Disease-Free Survival; Female; Genotype; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasms; Niacinamide; Pharmacogenetics; Phenylurea Compounds; Pilot Projects; Polymorphism, Genetic; Prostatic Neoplasms; Pyridines; Sorafenib; UDP-Glucuronosyltransferase 1A9

2012
Sorafenib inhibits liver regeneration in rats.
    HPB : the official journal of the International Hepato Pancreato Biliary Association, 2013, Volume: 15, Issue:12

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Body Weight; Cell Proliferation; Hepatectomy; Ki-67 Antigen; Liver; Liver Regeneration; Niacinamide; Organ Size; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Wistar; Sorafenib; Time Factors

2013
Transarterial embolization with sorafenib in animal livers: a pharmacokinetics study.
    Journal of vascular and interventional radiology : JVIR, 2013, Volume: 24, Issue:11

    Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Bilirubin; Chemoembolization, Therapeutic; Chromatography, High Pressure Liquid; Ethiodized Oil; Feasibility Studies; gamma-Glutamyltransferase; Hepatic Artery; Liver; Male; Models, Animal; Niacinamide; Phenylurea Compounds; Rabbits; Sorafenib; Tandem Mass Spectrometry

2013
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; Female; France; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prognosis; Retrospective Studies; Serum Albumin; Severity of Illness Index; Sorafenib; Survival Analysis; United Kingdom; Young Adult

2016
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
    Biochemical pharmacology, 2017, 04-01, Volume: 129

    Topics: Bilirubin; Catalysis; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Indazoles; Kinetics; Lapatinib; Microsomes, Liver; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Quinazolines; Sorafenib; Sulfonamides

2017
The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development.
    Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; Databases, Factual; Disease Progression; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Patient Selection; Phenylurea Compounds; Prospective Studies; Sorafenib

2017
Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:12

    Topics: Aged; Albuminuria; Antineoplastic Agents; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Sorafenib; Survival Rate; Treatment Failure

2017
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 86

    Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Decision Support Techniques; Disease-Free Survival; Female; France; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Proportional Hazards Models; Protein Kinase Inhibitors; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin, Human; Sorafenib; Time Factors; Treatment Outcome; Tumor Burden; United Kingdom

2017
Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article.
    Medicine, 2018, Volume: 97, Issue:17

    Topics: Adult; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; International Normalized Ratio; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prognosis; Retrospective Studies; Risk Factors; Sorafenib; Treatment Outcome

2018